SAR342434
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SAR342434, covering 2014-10-23 to 2018-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine [Phase 3]